News

vTv Therapeutics Announces Issuance of U.S. Patent for Azeliragon as a Treatment of Glioblastoma to Cantex Pharmaceuticals

vTv discovered small molecule RAGE inhibitor being developed by Cantex under worldwide development and commercialization agreementHIGH POINT, N.C., May 24,…

2 years ago

INmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening SessionBOCA RATON, Fla., May 24, 2023 (GLOBE NEWSWIRE) --…

2 years ago

H1 Partners with The Michael J. Fox Foundation to Transform Parkinson’s Disease Studies

The Foundation will use H1’s Trial Landscape solution to streamline communication with physicians treating Parkinson’s, improve representation in clinical studies,…

2 years ago

Thousands of Canadians Coast to Coast Walk Together In Support of Those Affected by Multiple Sclerosis

TORONTO, May 24, 2023 (GLOBE NEWSWIRE) -- On May 28, Canadians coast to coast will come together to take part…

2 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

LANGHORNE, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of…

2 years ago

Zeda Opens Advanced Manufacturing Digital Foundry in Cincinnati, Ohio

Zeda Opens Advanced Manufacturing Digital Foundry in Cincinnati, Ohio Steve Rengers, Senior Vice President of Zeda, Inc. at the new…

2 years ago

The Belgian Brand Using Maca Root to Naturally Boost Libido

Male Plus’s Unique Formula Utilizes Natural Ingredients to Stimulate Sexual Desire. One of These Is Maca Root.Fort Lauderdale, FL, May…

2 years ago

Male Plus Is Enhancing Men’s Libidos By Destressing Their Minds

The Brand’s Natural Formula Stimulates the Body While Calming the Mind, Making It Easier to Get in the MoodFort Lauderdale,…

2 years ago

Aerami Therapeutics Announces Pharmacokinetic Data Demonstrating the Potential of AER-901 (Inhaled Imatinib) to Achieve Therapeutic Levels at Low Inhaled Doses for Treatment of Pulmonary Hypertension

DURHAM, N.C., May 24, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life…

2 years ago

Palisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts

Company approaching Phase 2 topline data readout for prevention of post-surgical abdominal adhesions Continued momentum with execution of ongoing dose…

2 years ago